Literature DB >> 15510791

Clinical study on electro-acupuncture treatment for 30 cases of mental depression.

Cui Han1, Xiaohong Li, Hechun Luo, Xueying Zhao, Xuewu Li.   

Abstract

UNLABELLED: To observe the clinical therapeutic effects of electro-acupuncture therapy for mental depression, 30 cases were treated by electro-acupuncture on Baihui (GV20), Yintang (EX-HN3) and the differential points. Maprotiline was used in the control group of 31 cases. After the treatment, the scores in HAMD for both groups were found to be obviously decreased as compared with those before the treatment (P < 0.01), without significant between-group differences (P > 0.05). The total effective rate in the treatment group was 96.7%, and that of the control group was 90.3%, showing no significant between-group differences (P > 0.05). After the treatment, the two groups all showed obvious decrease in the TCM symptomatic integrals (P < 0.01), with significant between-group differences (P < 0.05), the integral of the treatment group showing obvious superiority to that of the control group. And the decrease of the Asberg scores testing the side effect of antidepressants of the treatment group was obviously superior to that of the control group. After the treatment, the cortisol (CORT) content and the endothelin-1 (ET-1) content of the two groups were all obviously decreased (P < 0.01), and basically turned to normal, without significant between-group differences (P > 0.05).
CONCLUSION: Electro-acupuncture, therapy can produce the same clinical therapeutic effect as that produced by the tetracyclic drug maprotiline, giving less side effect and better symptomatic improvement.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15510791

Source DB:  PubMed          Journal:  J Tradit Chin Med        ISSN: 0255-2922            Impact factor:   0.848


  7 in total

1.  The status and future of acupuncture clinical research.

Authors:  Jongbae Park; Klaus Linde; Eric Manheimer; Albrecht Molsberger; Karen Sherman; Caroline Smith; Joseph Sung; Andrew Vickers; Rosa Schnyer
Journal:  J Altern Complement Med       Date:  2008-09       Impact factor: 2.579

2.  Transcutaneous Electrical Cranial-Auricular Acupoint Stimulation vs. Escitalopram for Patients With Mild-to-Moderate Depression (TECAS): Study Design for a Randomized Controlled, Non-inferiority Trial.

Authors:  Sichang Yang; Zongshi Qin; Xinjing Yang; Mei Yan Chan; Shuiyan Zhang; Peijing Rong; Xiaobing Hou; Guixing Jin; Fengquan Xu; Yong Liu; Zhang-Jin Zhang
Journal:  Front Psychiatry       Date:  2022-05-10       Impact factor: 5.435

3.  A randomized trial of transcutaneous electric acupoint stimulation as adjunctive treatment for opioid detoxification.

Authors:  Christina S Meade; Scott E Lukas; Leah J McDonald; Garrett M Fitzmaurice; Jessica A Eldridge; Nancy Merrill; Roger D Weiss
Journal:  J Subst Abuse Treat       Date:  2009-07-01

4.  Electroacupuncture upregulates ERK signaling pathways and promotes adult hippocampal neural progenitors proliferation in a rat model of depression.

Authors:  Liu Yang; Na Yue; Xiaocang Zhu; Qiuqin Han; Qiong Liu; Jin Yu; Gencheng Wu
Journal:  BMC Complement Altern Med       Date:  2013-10-28       Impact factor: 3.659

5.  Clinical studies on treatment of earthquake-caused posttraumatic stress disorder using electroacupuncture.

Authors:  Yu Wang; You-Ping Hu; Wen-Chun Wang; Ri-Zhao Pang; An-Ren Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2012-09-25       Impact factor: 2.629

Review 6.  The effectiveness of acupuncture research across components of the trauma spectrum response (tsr): a systematic review of reviews.

Authors:  Courtney Lee; Cindy Crawford; Dawn Wallerstedt; Alexandra York; Alaine Duncan; Jennifer Smith; Meredith Sprengel; Richard Welton; Wayne Jonas
Journal:  Syst Rev       Date:  2012-10-15

7.  Locating the Acupoint Baihui (GV20) Beneath the Cerebral Cortex with MRI Reconstructed 3D Neuroimages.

Authors:  Ein-Yiao Shen; Fun-Jou Chen; Yun-Yin Chen; Ming-Fan Lin
Journal:  Evid Based Complement Alternat Med       Date:  2011-02-14       Impact factor: 2.629

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.